Biological Specimen Banks
Microscopy, Electron, Scanning Transmission
Holography
Electron Microscope Tomography
Specimen Handling
Spectroscopy, Electron Energy-Loss
Tissue Embedding
Gas Chromatography-Mass Spectrometry
Microscopy
Substance Abuse Detection
Cryoelectron Microscopy
Imaging, Three-Dimensional
Microscopy, Fluorescence, Multiphoton
Chromatography, Gas
Sensitivity and Specificity
Reproducibility of Results
Electrons
Image Processing, Computer-Assisted
Reference Standards
Fatal Outcome
Microscopy, Confocal
Chromatography, High Pressure Liquid
Microscopy, Fluorescence
Accessory DNA in the genomes of representatives of the Escherichia coli reference collection. (1/285)
Different strains of the Escherichia coli reference collection (ECOR) differ widely in chromosomal size. To analyze the nature of the differential gene pool carried by different strains, we have followed an approach in which random amplified polymorphic DNA (RAPD) was used to generate several PCR fragments. Those present in some but not all the strains were screened by hybridization to assess their distribution throughout the ECOR collection. Thirteen fragments with various degrees of occurrence were sequenced. Three of them corresponded to RAPD markers of widespread distribution. Of these, two were housekeeping genes shown by hybridization to be present in all the E. coli strains and in Salmonella enterica LT2; the third fragment contained a paralogous copy of dnaK with widespread, but not global, distribution. The other 10 RAPD markers were found in only a few strains. However, hybridization results demonstrated that four of them were actually present in a large selection of the ECOR collection (between 42 and 97% of the strains); three of these fragments contained open reading frames associated with phages or plasmids known in E. coli K-12. The remaining six fragments were present in only between one and four strains; of these, four fragments showed no similarity to any sequence in the databases, and the other two had low but significant similarity to a protein involved in the Klebsiella capsule synthesis and to RNA helicases of archaeal genomes, respectively. Their percent GC, dinucleotide content, and codon adaptation index suggested an exogenous origin by horizontal transfer. These results can be interpreted as reflecting the presence of a large pool of strain-specific genes, whose origin could be outside the species boundaries. (+info)Intraspecific diversity of the 23S rRNA gene and the spacer region downstream in Escherichia coli. (2/285)
The molecular microevolution of the 23S rRNA gene (rrl) plus the spacer downstream has been studied by sequencing of different operons from some representative strains of the Escherichia coli ECOR collection. The rrl gene was fully sequenced in six strains showing a total of 67 polymorphic sites, a level of variation per nucleotide similar to that found for the 16S rRNA gene (rrs) in a previous study. The size of the gene was highly conserved (2902 to 2905 nucleotides). Most polymorphic sites were clustered in five secondary-structure helices. Those regions in a large number of operons were sequenced, and several variations were found. Sequences of the same helix from two different strains were often widely divergent, and no intermediate forms existed. Intercistronic variability was detected, although it seemed to be lower than for the rrs gene. The presence of two characteristic sequences was determined by PCR analysis throughout all of the strains of the ECOR collection, and some correlations with the multilocus enzyme electrophoresis clusters were detected. The mode of variation of the rrl gene seems to be quite similar to that of the rrs gene. Homogenization of the gene families and transfer of sequences from different clonal lines could explain this pattern of variation detected; perhaps these factors are more relevant to evolution than single mutation. The spacer region between the 23S and 5S rRNA genes exhibited a highly polymorphic region, particularly at the 3' end. (+info)Mouse ENU mutagenesis. (3/285)
The progress of human genome sequencing is driving genetic approaches to define gene function. Strategies such as gene traps and chemical mutagenesis will soon generate a large mutant mouse resource. Point mutations induced by N -ethyl- N -nitrosourea (ENU) provide a unique mutant resource because they: (i) reflect the consequences of single gene change independent of position effects; (ii) provide a fine-structure dissection of protein function; (iii) display a range of mutant effects from complete or partial loss of function to exaggerated function; and (iv) discover gene functions in an unbiased manner. Phenotype-driven ENU screens in the mouse are emphasizing relevance to human clinical disease by targeting cardiology, physiology, neurology, immunity, hematopoiesis and mammalian development. Such approaches are extremely powerful in understanding complex human diseases and traits: the base-pair changes may accurately model base changes found in human diseases, and subtle mutant alleles in a standard genetic background provide the ability to analyze the consequences of compound genotypes. Ongoing mouse ENU mutagenesis experiments are generating a treasure trove of new mutations to allow an in-depth study of a single gene, a chromosomal region or a biological system. (+info)Distribution of intervening sequences in the genes for 23S rRNA and rRNA fragmentation among strains of the Salmonella reference collection B (SARB) and SARC sets. (4/285)
Intervening sequences (IVSs) occur sporadically in several bacterial genera in the genes for 23S rRNA at relatively conserved locations. They are cleaved after transcription and lead to the presence of fragmented rRNA, which is incorporated into the ribosomes without religation but is nevertheless functional. The fragmentation of rRNA and the number of IVSs in all 72 strains of the Salmonella Reference Collection B set and 16 strains of the Salmonella Reference Collection C set, which have been established on the basis of multilocus enzyme electrophoresis (MLEE), were analyzed in the present study. Fragmentation of 23S rRNA was restricted to conserved cleavage sites located at bp 550 (helix 25) and bp 1170 (helix 45), locations where IVSs have been reported. Random cleavage at sites where IVSs could not be detected was not seen. Uncleaved IVSs were not detected in any case; thus, the IVSs invariably led to rRNA fragmentation, indicating a strong selection for maintenance of RNase III cleavage sites. The distribution of the number of IVSs carried by the different strains in the seven rrl genes is diverse, and the pattern of IVS possession could not be related to the MLEE pattern among the various Salmonella strains tested; this indicates that the IVSs are frequently exchanged between strains by lateral transfer. All eight subspecies of the genus Salmonella, including subspecies V represented by Salmonella bongori, have IVSs in both helix 25 and helix 45; this indicates that IVSs entered the genus after its divergence from Escherichia coli (more than 100 million years ago) but before separation of the genus Salmonella into many forms or that they were in the ancestor but have been lost from Escherichia. (+info)Differences in genotypes of Helicobacter pylori from different human populations. (5/285)
DNA motifs at several informative loci in more than 500 strains of Helicobacter pylori from five continents were studied by PCR and sequencing to gain insights into the evolution of this gastric pathogen. Five types of deletion, insertion, and substitution motifs were found at the right end of the H. pylori cag pathogenicity island. Of the three most common motifs, type I predominated in Spaniards, native Peruvians, and Guatemalan Ladinos (mixed Amerindian-European ancestry) and also in native Africans and U.S. residents; type II predominated among Japanese and Chinese; and type III predominated in Indians from Calcutta. Sequences in the cagA gene and in vacAm1 type alleles of the vacuolating cytotoxin gene (vacA) of strains from native Peruvians were also more like those from Spaniards than those from Asians. These indications of relatedness of Latin American and Spanish strains, despite the closer genetic relatedness of Amerindian and Asian people themselves, lead us to suggest that H. pylori may have been brought to the New World by European conquerors and colonists about 500 years ago. This thinking, in turn, suggests that H. pylori infection might have become widespread in people quite recently in human evolution. (+info)Cancer gene discovery using digital differential display. (6/285)
The Cancer Gene Anatomy Project database of the National Cancer Institute has thousands of expressed sequences, both known and novel, in the form of expressed sequence tags (ESTs). These ESTs, derived from diverse normal and tumor cDNA libraries, offer an attractive starting point for cancer gene discovery. Using a data-mining tool called Digital Differential Display (DDD) from the Cancer Gene Anatomy Project database, ESTs from six different solid tumor types (breast, colon, lung, ovary, pancreas, and prostate) were analyzed for differential expression. An electronic expression profile and chromosomal map position of these hits were generated from the Unigene database. The hits were categorized into major classes of genes including ribosomal proteins, enzymes, cell surface molecules, secretory proteins, adhesion molecules, and immunoglobulins and were found to be differentially expressed in these tumorderived libraries. Genes known to be up-regulated in prostate, breast, and pancreatic carcinomas were discovered by DDD, demonstrating the utility of this technique. Two hundred known genes and 500 novel sequences were discovered to be differentially expressed in these select tumor-derived libraries. Test genes were validated for expression specificity by reverse transcription-PCR, providing a proof of concept for gene discovery by DDD. A comprehensive database of hits can be accessed at http:// www.fau.edu/cmbb/publications/cancergenes. htm. This solid tumor DDD database should facilitate target identification for cancer diagnostics and therapeutics. (+info)exl, an exchangeable genetic island in Neisseria meningitidis. (7/285)
The genetic structure and evolution of a novel exchangeable meningococcal genomic island was defined for the important human pathogen Neisseria meningitidis. In 125 meningococcal strains tested, one of three unrelated nucleotide sequences, designated exl (exchangeable locus), was found between a gene required for heme utilization, hemO, and col, encoding a putative Escherichia coli collagenase homologue. The 5' boundary of each exl cassette was the stop codon of hemO, whereas the 3' boundary was delineated by a 33-bp repeat containing neisserial uptake sequences located downstream of col. One of the three alternative exl cassettes contained the meningococcal hemoglobin receptor gene, hmbR (exl3). In other meningococcal strains, hmbR was absent from the genome and was replaced by either a nucleotide sequence containing a novel open reading frame, exl2, or a cassette containing exl3. The proteins encoded by exl2 and exl3 had no significant amino acid homology to HmbR but contained six motifs that are also present in the lipoprotein components of the lactoferrin (LbpB), transferrin (TbpB), and hemoglobin-haptoglobin (HpuA) uptake systems. To determine the evolutionary relationships among meningococci carrying hmbR, exl2, or exl3, isolates representing 92 electrophoretic types were examined. hmbR was found throughout the population structure of N. meningitidis (genetic distance, >0.425), whereas exl2 and exl3 were found in clonal groups at genetic distances of <0.2. The commensal neisserial species were identified as reservoirs for all of the exl cassettes found in meningococci. The structure of these cassettes and their correlation with clonal groups emphasize the extensive gene pool and frequent horizontal DNA transfer events that contribute to the evolution and virulence of N. meningitidis. (+info)Recent events and observations pertaining to smallpox virus destruction in 2002. (8/285)
To destroy all remaining stocks of variola virus on or before 31 December 2002 seems an even more compelling goal today than it did in 1999, when the 52d World Health Assembly authorized temporary retention of remaining stocks to facilitate the possible development of (1) a more attenuated, less reactogenic smallpox vaccine and (2) an antiviral drug that could be used in treatment of patients with smallpox. We believe the deadline established in 1999 should be adhered to, given the potential outcomes of present research. Although verification that every country will have destroyed its stock of virus is impossible, it is reasonable to assume that the risk of a smallpox virus release would be diminished were the World Health Assembly to call on each country to destroy its stocks of smallpox virus and to state that any person, laboratory, or country found to have virus after date x would be guilty of a crime against humanity. (+info)Biological specimen banks, also known as biobanks or biorepositories, are facilities that collect, store, and manage biological samples, such as blood, tissue, and DNA, for research and medical purposes. These banks are designed to ensure the long-term preservation of the samples and to provide researchers with access to them for future studies. Biological specimen banks play a critical role in advancing medical research and improving patient care. They allow researchers to study the underlying causes of diseases, develop new treatments, and identify biomarkers that can be used to diagnose and monitor diseases. They also provide a valuable resource for clinical trials, where researchers can use the stored samples to test new drugs and therapies. To ensure the quality and integrity of the samples, biological specimen banks typically follow strict protocols for collection, processing, storage, and distribution. They may also be subject to regulatory oversight to ensure that the samples are used ethically and that the privacy and confidentiality of the donors are protected.
Cryoelectron microscopy (cryo-EM) is a technique used in the medical field to study the structure of biological molecules and cells at the atomic level. It involves using a beam of electrons to image frozen-hydrated samples, which are typically biological molecules or cells that have been frozen and then rapidly plunged into a liquid nitrogen bath to preserve their structure. Cryo-EM is particularly useful for studying large or complex biological structures that are difficult to study using other techniques, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. It can also be used to study dynamic processes, such as the movement of molecules or the interactions between different components of a biological system. Cryo-EM has been instrumental in advancing our understanding of many important biological processes, including the functioning of enzymes, the structure of viruses, and the mechanisms of diseases such as Alzheimer's and Parkinson's. It has also been used to develop new drugs and therapies for a variety of medical conditions.
Gas chromatography (GC) is a technique used in the medical field to separate and analyze volatile compounds in a sample. It is a type of chromatography that uses a gas as the mobile phase to separate the components of a mixture based on their volatility and interaction with the stationary phase. In GC, a sample is injected into a heated column packed with a stationary phase, which is typically a solid or liquid coated onto a small diameter column. The sample components are then carried through the column by a carrier gas, such as helium or nitrogen, which flows through the column at a constant rate. As the sample components pass through the column, they interact with the stationary phase and are separated based on their volatility and affinity for the stationary phase. The separated components are then detected and quantified using a detector, such as a flame ionization detector or mass spectrometer. GC is commonly used in the medical field to analyze a wide range of samples, including biological fluids, drugs, and environmental samples. It is particularly useful for analyzing volatile organic compounds, such as those found in breath or blood, and is often used in the diagnosis and monitoring of diseases such as diabetes, liver disease, and lung cancer.
High-pressure liquid chromatography (HPLC) is a technique used in the medical field to separate and analyze complex mixtures of compounds. It involves the use of a liquid mobile phase that is forced through a column packed with a stationary phase under high pressure. The compounds in the mixture interact with the stationary phase to different extents, causing them to separate as they pass through the column. The separated compounds are then detected and quantified using a detector, such as a UV detector or a mass spectrometer. HPLC is commonly used in the analysis of drugs, biological samples, and other complex mixtures in the medical field.
Blood banks are facilities that collect, process, store, and distribute blood and blood products for medical use. They play a critical role in ensuring the availability of blood for patients who require transfusions, such as those undergoing surgery, suffering from trauma, or suffering from certain medical conditions. Blood banks typically have a variety of blood products available, including whole blood, red blood cells, platelets, and plasma. They also perform tests on donated blood to ensure that it is safe for transfusion and to identify any potential risks or complications. Blood banks are regulated by government agencies, such as the Food and Drug Administration (FDA) in the United States, to ensure that they meet strict standards for safety and quality. They also work closely with healthcare providers to ensure that blood is available when and where it is needed.
In the medical field, algorithms are a set of step-by-step instructions used to diagnose or treat a medical condition. These algorithms are designed to provide healthcare professionals with a standardized approach to patient care, ensuring that patients receive consistent and evidence-based treatment. Medical algorithms can be used for a variety of purposes, including diagnosing diseases, determining the appropriate course of treatment, and predicting patient outcomes. They are often based on clinical guidelines and best practices, and are continually updated as new research and evidence becomes available. Examples of medical algorithms include diagnostic algorithms for conditions such as pneumonia, heart attack, and cancer, as well as treatment algorithms for conditions such as diabetes, hypertension, and asthma. These algorithms can help healthcare professionals make more informed decisions about patient care, improve patient outcomes, and reduce the risk of medical errors.
Zoological specimen
Biomedical tissue
Cell bank
International Thylacine Specimen Database
Transmission electron cryomicroscopy
Leucospermum
Biobank
Laboratory Response Network
Breast International Group
EM Data Bank
Helga Margrét Ögmundsdóttir
Olga Sansom
List of MeSH codes (N02)
Biorepository
Elsayed Elsayed Wagih
Chrysogaster antitheus
Suzanne Anker
Genomic Medicine Institute
List of biological databases
Research station
EuroBioBank
Croatian Natural History Museum
List of giant squid specimens and sightings
List of giant squid specimens and sightings (20th century)
Craugastor phasma
Health Sciences Authority
Badgeworth SSSI, Gloucestershire
Richard C. Banks
Teratohyla adenocheira
William Morton Wheeler
Zoological specimen - Wikipedia
Advanced Search Results - Public Health Image Library(PHIL)
Lady Bird Johnson Wildflower Center - The University of Texas at Austin
Kao, David | Colorado PROFILES
Cells | Free Full-Text | Biallelic Variants in ENDOG Associated with Mitochondrial Myopathy and Multiple mtDNA Deletions
BVS Brasil
Neuroscience Center | Research & Innovation | Boston Children's Hospital
ATSDR's ALS Registry Launches the ALS Biorepository | Blogs | CDC
Trypanosomiasis, African | WHO | Regional Office for Africa
JACC in a Flash - American College of Cardiology
NHANES 2013-2014 Laboratory Data Overview
MeSH Browser
Binil Starly - Citation Index - NCSU Libraries
SI Research Notes: National Museum of Natural History | Smithsonian Voices | blog | Smithsonian Journeys
DeCS
Iñigo Manglano-Ovalle - John Simon Guggenheim Memorial Foundation...
Editorial Comment: Fluid Intake and Dietary Factors and the Risk of Incident Kidney Stones in UK Biobank: A Population-based...
UCSF Askin Tumor Trial → Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Reflections on dynamic consent in biomedical research: the story so far. - Centre for Medicines Discovery (CMD)
Response to: One size does not fit all-application of accelerometer thresholds in chronic disease. - Oxford Big Data Institute
CERTIFIED SHORT TRAINING COURSES - INTERNATIONAL PROGRAMS | Center for Biomedical Science and Cellmolecules Inc Partners
Suzanne Anker - Vanitas (in a Petri dish) 38 for Sale | Artspace
Registries and Repositories - | New Jersey Alliance for Clinical and Translational Science | NJ ACTS
Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. - Peter...
Compound Management - Global Market Outlook (2018-2027) | Stratistics MRC
Pesquisa | Portal Regional da BVS
Technology and Biological Resource
Humans1
- Toxicology and biological monitoring of metals in humans. (cdc.gov)
Biorepository4
- Biorepository Pilot Study is to pilot methods for collecting and banking biological specimens from participants in the National ALS Registry. (cdc.gov)
- The National ALS Biorepository is an exciting new component of the National ALS Registry that will increase the number of biological samples from persons with ALS available for research. (cdc.gov)
- The new National ALS Biorepository will collect, process, store, and disseminate a variety of biological specimens such as blood, urine, and tissue from a sample of persons with ALS enrolled in the National ALS Registry who agree to take part in the Biorepository. (cdc.gov)
- The National ALS Biorepository is different from other biorepositories because it collects specimens from a geographically representative sample of people with ALS that is not tied to a specific clinic or location. (cdc.gov)
Urine5
- Participants aged 6 and older were asked to provide a full void of urine in the MEC using a specimen cup. (cdc.gov)
- The date and time of the last urine void, along with the date, time, and volume of the urine specimen collected in the MEC were used to provide a measurement of urine flow rate. (cdc.gov)
- A random half of those who completed the initial 24-hour urine collection were recruited to collect a second 24-hour urine specimen 3 to 10 days later. (cdc.gov)
- In 2014, participants who completed the initial 24-hour urine collection were also asked to collect another two urine specimens: a void in the evening and the first void the following morning. (cdc.gov)
- After completing the 24-hour urine collection, participants were instructed to collect these two full voids at home in separate specimen cups and mail them back to the contract laboratory. (cdc.gov)
Collects1
- NHANES collects biological specimens (biospecimens) for laboratory analysis to provide detailed information about participants' health and nutritional status. (cdc.gov)
Participants4
- ATSDR conducted a study from 2011-2015 to pilot methods for collecting and banking biological specimens from participants in ATSDR's Registry. (cdc.gov)
- The pilot study recruited a nationally representative sample of patients enrolled in Registry and included two specimen collection components: biological specimens from living participants (in-home) and postmortem specimens. (cdc.gov)
- The examining dentist instructed participants aged 14-69 to gargle and swish with mouthwash for 30 seconds and then spit into a specimen container. (cdc.gov)
- Female and male participants aged 14-59 were asked to self-collect a vaginal or penile specimen using a sterile swab. (cdc.gov)
Clinical data3
- The Repository Core for Neurological Disorders, for example, is a database and biological specimen bank of high-quality clinical data with paired DNA and protein samples from patients. (childrenshospital.org)
- Collect biological specimens, including associated demographic and clinical data, from patients with Ewing sarcoma . (ucsf.edu)
- Make collected specimens available to qualified researchers to understand the biology of Ewing sarcoma and correlate these results with demographic and clinical data. (ucsf.edu)
Protocols1
- These protocols must be outlined and submitted to the IRB for review and approval prior to starting research using the specimens. (rutgers.edu)
Diagnosis1
- Patients undergo collection of tumor specimens, bone marrow, and peripheral blood at diagnosis. (ucsf.edu)
Samples3
- There are now over 126 million specimens in the ever-growing NMNH collections, ranging from DNA samples to whale skulls, African baskets to Chinese shoes, algae samples to petrified logs, tiny crustaceans to giant squid, Moon rocks to the Hope diamond, and Tyrannosaurus rex bones to the oldest fossils from the Burgess Shale. (smithsonianjourneys.org)
- Blubber samples from Alaska ringed seal (Phoca hispida) were collected for inclusion in the US National Biomonitoring Specimen Bank, as well as for immediate analysis as part of the contaminant monitoring component of the US National Marine Fisheries Service's Marine Mammal Health and Stranding Response Program. (amap.no)
- Close involvement of the pathology department at Importance of BRCs col ecting centres is essential to facilitate the use of banked fresh frozen samples in diagnostic procedures. (who.int)
Collection2
Patients1
- Une étude transversale comportant des entretiens a montré que 68,8 % des 1051 patients interrogés en consultation externe dans un hôpital de Riyad montraient une attitude positive au sujet de la recherche biomédicale. (who.int)
Tissue banks2
- Registries refer to data banks whereas repositories refer to tissue banks that store information over time. (rutgers.edu)
- Therefore it is recommended that comprehensive of biomedical sciences: molecular and genetic cancer centres and academic medical centres have epidemiology (aimed at assessing the genetic and wel -organized BRCs that actively cooperate in environmental basis of cancer causation in the general national and international networks of tissue banks. (who.int)
Research6
- Registries and Repositories involve the storage of information and biological specimens acquired from research. (rutgers.edu)
- Different bio-specimens stored at bio-banks are observing significant demand because of the improvements in cell-based research activities. (strategymrc.com)
- The biological resources facility provides the research and teaching needs of the researchers, faculty members and scientists from private industry and other agencies under conditions required by local and federal regulatory agencies. (consortiumpublisher.ca)
- The biological resources established to serve the research faculty of the academic and industries of life sciences. (consortiumpublisher.ca)
- BRCs are important for developing personalised of biological research. (who.int)
- Human biological specimens have been used for of a number of molecular parameters and will require many decades for translational purposes in cancer systematic preservation of frozen biospecimens or research, in particular for testing hypotheses and derived biomaterial. (who.int)
High-quality1
- Thus, Firstly, the rights of the individuals whose tissues development of high-quality BRCs has the potential or biological specimens are to be included in the to accelerate and facilitate this translational process. (who.int)
Term1
- Provide a repository for long-term storage of Ewing sarcoma-related biological materials. (ucsf.edu)
Health1
- Worse, markets and banks had been subjected to regular health checks by darknet drug links the The wolf pack quickly disposed of Iceland and Hungary, before in October. (kingdommarket-online.com)
Human4
- Our results support the robustness of the additive model when modeling human complex traits, consistent with the view that most common variants induce small perturbations of continuous latent biological processes aggregated by a mean-field approximation. (cdc.gov)
- Therefore, studies on human specimens are also may rapidly become part of recommended, if not becoming critical in the process of discovering mandatory, medical practice. (who.int)
- Thus, gathering know- new mechanisms involved in causing cancer or in how and procedures for col ecting, storing and determining its progression, resistance/response analyzing human specimens is a major contribution to treatment and clinical outcome. (who.int)
- Access to human biological specimens is often a prerequisite for such R&D advances. (who.int)
Search1
- In the past few years his work has found him involved in washing and breaking the windows of Mies Van Der Rohe buildings, building radio-telescopes to search for extraterrestrials on the Mexican border with the U.S., creating cryogenic sperm banks for archiving specimens on loan from artists and curators, monitoring heroin poppies with military night vision, as well as capturing actual clouds and icebergs. (gf.org)
Data banks1
- Natural history collections serve inevitably as data banks. (smithsonianjourneys.org)
Storage2
- Operators of the investigators must have physical and procedural safeguards implemented for the secure, receipt, storage, and transmission of specimens. (rutgers.edu)
- After 24 hour storage in distilled water at 37°C, the specimens were submitted to the tensile bond strength test. (bvsalud.org)
Major1
- Development of the bio-banking sector, rising outsourcing of sample management and high improvement in the biopharmaceutical industry are the major factors driving the market growth. (strategymrc.com)
Local1
- COUNEX committee at TCDC (composed of ferent kinds of biological hazards is increased through fre- members from all 4 local branches)§ quent travel and commercial activities ( 1 - 5 ). (cdc.gov)
Variety1
- She works in a variety of mediums ranging from digital sculpture and installation to large-scale photography as well as botanical specimens. (artspace.com)
Materials1
- In: Analysis of hazardous substances in biological materials. (cdc.gov)
Sample1
- Based on the sample type, the segment of the biological sample is likely to have a huge demand due to the increasing demand for personalized medicines. (strategymrc.com)
Methods1
- In: Biological monitoring methods for industrial chemicals. (cdc.gov)
Study1
- The study was published online February 3 in Biological Psychiatry . (medscape.com)
Analysis1
- 1979. Quantitative trace analysis of thallium in biological material. (cdc.gov)
Institutions1
- The Smithsonian's Natural History programs are collaborative and each year thousands of specimens are lent to institutions around the United States as well as around the world. (smithsonianjourneys.org)
Medical1
- If an autopsy was performed, whenever and unexplained death investigation due to unknown infec- possible tissue specimens were examined by pathologists of TCDC-designated medical centers and the Forensic Department of tious causes (COUNEX) (Figure). (cdc.gov)
Conditions1
- Conditions (if any) under which the subject may withdraw their consent/authorization to use of specimens. (rutgers.edu)